NASDAQ:CSTL

Castle Biosciences, Inc Earning Date

USA |NASDAQ |USD

CSTL Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 8, 2021 Sep 2021 $-0.40 $-0.35 $-0.23
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 8, 2021 Sep 2021 $22.97M $22.76M $15.22M

Castle Biosciences, Inc's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.

CSTL Earnings Date & History Chart

CSTL Earnings & Revenue Forecast

CSTL Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-0.39 $-0.48 $-0.19
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-1.35 $-1.49 $-1.22
Dec 2022 6 $-1.11 $-2.14 $-0.36

CSTL Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.39 $-0.30 $-0.30
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.35 $-1.22 $-1.22
Dec 2022 0 / 0 $-1.11 $-0.76 $-0.76

CSTL Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 6 $24.08M $23.30M $27.40M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $91.86M $91.00M $92.98M
Dec 2022 6 $112.45M $104.50M $121.10M

CSTL Earnings Date & Revenue History

CSTL Earnings History

|
Show More
Show More

CSTL Revenue History

|
Show More
Show More

Castle Biosciences, Inc Next Earnings Date & Report

CSTL Next Earnings Date & Report Preview: Sep 2021 (FQ)

CSTL's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 6 analysts, the average EPS estimation for Castle Biosciences, Inc's next quarterly earnings is $-0.40, with a low EPS estimation of $-0.49, and a high estimation of $-0.32.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.40, the last 2 month trend is $-0.34, and the 3 month trend is $-0.34.

Based on 6 analysts, the average revenue estimation is $22.97M, with a low revenue estimation of $22.10M, and a high estimation of $23.82M.

Castle Biosciences, Inc Previous Earnings Dates & Reports

CSTL Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Castle Biosciences, Inc's previous earnings date was Aug 9, 2021 for its fiscal quarter ended Jun 30, 2021.

CSTL's earnings per share (EPS) was $-0.35, beating the consensus analysts forecast of $-0.37 by 4.37%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 105.88%, and lower than the same period a year before (Jun 2020) by 337.50%.

Revenues were $22.76M, better than the forecast of $18.92M by 20.29%, down by -0.24% from the previous quarter , and up by 78.99% from the same period last year.

The company reported a net income of $-8.79M.

Free cash flow for the quarter was $-11.73M , compared to $-4.38M last quarter and $11.74M a year before.

CSTL Previous Earnings Date & Report Recap: Dec 2020 (FY)

Castle Biosciences, Inc's previous annual earnings date was Mar 8, 2021 for its fiscal year ended Dec 31, 2020.

CSTL's earnings per share (EPS) was $-0.51, missing the consensus analysts forecast of $-0.41 by 24.39% , and lower than the previous year's EPS (Dec 2019) by -1968.13%.

Revenues were $62.65M, better than the forecast of $61.12M by 2.50%, and up by 20.79% from previous year's revenue.

The company reported a net income of $-10.28M.

Castle Biosciences, Inc reported a free cash flow of $5.11M for its fiscal year, compared to $6.08M a year ago.